Showing results (181-190 of 204) with videos related to
Sort By:
Pageof 21
The Journal of Infectious Diseases|January 28, 2025
Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 YearsNicolas A Margot, Vamshi Jogiraju, Nina Pennetzdorfer, et al.Acta Anaesthesiologica Scandinavica|January 21, 2012
Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndromeA V Vanlander, P G Jorens, J Smet, et al.BMJ Open|July 21, 2021
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocolEmily Brown, Moon M Wilton, Victoria S Sprung, et al.Journal of Virology|January 22, 2000
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, M D Miller, M L Marthas, et al.The Journal of Clinical Endocrinology and Metabolism|November 9, 2018
Associations Between Pancreatic Lipids and β-Cell Function in Black African and White European Men With Type 2 DiabetesOlah Hakim, Riccardo C Bonadonna, Cynthia Mohandas, et al.American Journal of Physiology. Endocrinology and Metabolism|April 15, 2020
HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver diseaseMartin B Whyte, Fariba Shojaee-Moradie, Sharaf E Sharaf, et al.Science Translational Medicine|January 7, 2026
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defectsNina Pennetzdorfer, Vidula Naik, Sally Demirdjian, et al.Clinical Science (London, England : 1979)|October 2, 2015
Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver diseaseDaniel J Cuthbertson, Fariba Shojaee-Moradie, Victoria S Sprung, et al.Antiviral Therapy|February 4, 2012
Evidence for a shift to anaerobic metabolism in adipose tissue in efavirenz-containing regimens for HIV with different nucleoside backbonesKirsty C McGee, Mohsen Shahmanesh, Meg Boothby, et al.Clinical Science (London, England : 1979)|April 18, 2014
Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscleDaniel J Cuthbertson, Andrew Irwin, Victoria S Sprung, et al.Pageof 21